Trial record 6 of 10 for:    ogx-427

Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
OncoGenex Technologies
Hoosier Cancer Research Network
Information provided by (Responsible Party):
Noah Hahn, M.D., Hoosier Cancer Research Network
ClinicalTrials.gov Identifier:
NCT01780545
First received: January 25, 2013
Last updated: August 23, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2017
  Estimated Primary Completion Date: November 2016 (Final data collection date for primary outcome measure)